IL6 and depressive disorder: The same mechanisms likely contribute to the high incidence of depressive disorders reported in medically ill patients chronically treated with IFN-α [27] or in elderly subjects exhibiting systemic low-grade inflammation as manifested by increased serum levels of C-reactive protein (CRP) and interleukin-6 (IL-6) [28].